Stockach, Germany

Torsten Dunkern

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Nycomed Gmbh. Active years: 2010-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Torsten Dunkern. Retrieved from https://idiyas.com/inventor/torsten-dunkern-hkgy6zhy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2010-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Torsten Dunkern

Introduction

Torsten Dunkern is a notable inventor based in Stockach, Germany. He has made significant contributions to the field of medicine, particularly through his work with PDE5 inhibitors. With a total of 2 patents, Dunkern's innovations have the potential to impact various medical treatments.

Latest Patents

Dunkern's latest patents focus on the use of PDE5 inhibitors in medicine. These inventions explore the therapeutic applications of these compounds, which are known for their role in treating conditions such as erectile dysfunction and pulmonary hypertension. The emphasis on PDE5 inhibitors highlights Dunkern's commitment to advancing medical science.

Career Highlights

Throughout his career, Dunkern has been associated with Nycomed GmbH, a company known for its dedication to pharmaceutical advancements. His work at Nycomed has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to medical innovation.

Collaborations

Dunkern has worked alongside notable colleagues such as Christian Schudt and Friedrich Grimminger. These collaborations have fostered a creative environment that encourages the development of groundbreaking medical solutions.

Conclusion

Torsten Dunkern's work exemplifies the spirit of innovation in the medical field. His patents on PDE5 inhibitors demonstrate his dedication to improving healthcare through scientific advancements. The impact of his work is likely to resonate within the medical community for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…